Extendicare Inc. (TSE:EXE – Get Free Report) reached a new 52-week high on Tuesday . The stock traded as high as C$11.77 and last traded at C$11.67, with a volume of 49144 shares changing hands. The stock had previously closed at C$11.54.
Wall Street Analyst Weigh In
A number of analysts have commented on EXE shares. BMO Capital Markets set a C$11.00 price target on Extendicare and gave the stock a “market perform” rating in a research report on Thursday, January 30th. TD Securities increased their target price on shares of Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a report on Thursday, November 14th. Royal Bank of Canada lifted their price target on shares of Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a report on Thursday, November 28th. Finally, Cormark raised shares of Extendicare to a “moderate buy” rating in a research note on Wednesday, February 19th. Three investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of C$10.25.
View Our Latest Analysis on Extendicare
Extendicare Price Performance
Extendicare Announces Dividend
The firm also recently announced a monthly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 17th will be issued a $0.04 dividend. The ex-dividend date is Friday, February 28th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.16%. Extendicare’s dividend payout ratio (DPR) is presently 61.20%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- What is Insider Trading? What You Can Learn from Insider Trading
- February’s Top 3 Stock Upgrades: What Investors Need to Know
- How to trade using analyst ratings
- 2 Safe-Haven Stocks Shielded From Import Tariffs
- Investing In Preferred Stock vs. Common Stock
- Nebius Group: A Strategic Entry Point for Investors?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.